课题基金 / 基金详情

Osteoclast activation by radiolytic degradation of organic/inorganic double hybrid materials (DHM) for controlled enhanced degradation of bone substitute materials

Osteoclast activation by radiolytic degradation of organic/inorganic double hybrid materials (DHM) for controlled enhanced degradation of bone substitute materials
通过有机/无机双杂化材料(DHM)的辐射降解激活破骨细胞,以控制骨替代材料的增强降解
批准号:
497439310
负责人:
Dr.-Ing. Benjamin Kruppke
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Dr.-Ing. Benjamin Kruppke的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Starting point for this research project are supercritical bone defects, which have to be treated with a biomaterial to ensure a complete regeneration of the bone tissue. Such biomaterials are subject to a wide range of requirements, which can often only be met by combining different materials in a composite. This raises the question of how these components are arranged on different length scales, i.e. whether they follow a hierarchical structure following the bone model. This would increase the degrees of freedom to adapt the material to the target tissue. Following such a structure, important functions and properties, such as mechanical strength, degradation and resorbability, bone cell stimulation, etc., could be either separated or coupled.In order to meet this range of requirements, this project will investigate double hybrid materials (DHM), which correspond to the "brick and mortar" model often found in nature, as they consist of granules of a hybrid material and an organic matrix (collagen). The hybrid granules, in this case, are composed of an organic (collagen) and an inorganic (silica) component. This material system allows – by pre-treatment of the collagen in different stages of synthesis and by a choice of component ratios – to specifically modify the degradability of the DHM. The DHM can thus be adapted to bone regeneration and, if necessary, stimulate it. To this end, the collagen of the DHM (more precisely of their components) will be pre-damaged by radiolytic degradation using gamma irradiation to stimulate osteoclastic material resorption. The flexibility of the material system allows collagen to be used at all different levels of the hierarchy. Furthermore, the variable material synthesis allows the use of both radiation-treated and untreated collagen at all levels. Thus, the material can address osteoclast stimulation, i.e. accelerated resorbability, and rapid acellular degradation with simultaneous high mechanical strengths. In order to be able to guarantee this processes even in case of large bone defects and correspondingly large biomaterial specimens, a further hierarchical level will be added by means of extrusion-based 3D plotting. The DHM are processed by paste extrusion to macroporous scaffolds, whereby a void phase enables the accessibility of the strand surfaces for bone cells. Here, gamma irradiation serves to improve the viscoelastic properties of the matrix collagen to realize good processing via 3D plotting.In future, degradation and resorption of bone substitute materials might be adjustable according to the bone status and general patient condition via pre-treatment of the collagen-containing composites.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Crustacean bifunctional proteins in mineralized exoskeleton – a model for biomimetic injectable bone substitutes
  • 批准号:
    538923079
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Dr.-Ing. Benjamin Kruppke
  • 依托单位:
Resorbable Biopolymer Filaments for Drug Release in Gingival Pockets for Adjuvant Periodontitis Treatment
  • 批准号:
    495284435
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Dr.-Ing. Benjamin Kruppke
  • 依托单位:
国内基金
海外基金
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
  • 批准号:
    82371103
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮静
  • 依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
  • 批准号:
    82371799
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    杨程德
  • 依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
  • 批准号:
    82371223
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    闻大翔
  • 依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位: